Logo-bma
Biomed adv. 2026;3(2): 58-63. doi: 10.34172/bma.54

Review Article

Challenges and opportunities of the CRISPR/Cas9 system as an efficient genome editing tool in the development of medicinal plants: An updated mini- review

Hossein Soltaninejad 1 * ORCID, Mohadeseh Khoshandam 2, Elham Karimi 3, Reza Sheikhakbari 4, Mojdeh Hosseinpoor Kashani 5

Cited by CrossRef:


Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with